327 related articles for article (PubMed ID: 29971584)
1. Oral cyclophosphamide in treatment of patients with refractory idiopathic inflammatory myopathies: a retrospective observational study.
Bae S; Charles-Schoeman C
Clin Rheumatol; 2018 Aug; 37(8):2113-2123. PubMed ID: 29971584
[TBL] [Abstract][Full Text] [Related]
2. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Moreno-Torres V; Martín-Iglesias D; Vivero F; González-Echavarri C; García-Moyano M; Enghelmayer JI; Malfante P; Gaser A; Ruiz-Irastorza G;
Semin Arthritis Rheum; 2023 Apr; 59():152164. PubMed ID: 36773521
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review.
Ge Y; Peng Q; Zhang S; Zhou H; Lu X; Wang G
Clin Rheumatol; 2015 Jan; 34(1):99-105. PubMed ID: 25367345
[TBL] [Abstract][Full Text] [Related]
4. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
5. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies.
de Souza FHC; Miossi R; de Moraes JCB; Bonfá E; Shinjo SK
Adv Rheumatol; 2018 Sep; 58(1):31. PubMed ID: 30657080
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic inflammatory myopathies.
Amato AA; Griggs RC
Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
[TBL] [Abstract][Full Text] [Related]
8. Biologic therapy in the idiopathic inflammatory myopathies.
Khoo T; Limaye V
Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
Gandiga PC; Ghetie D; Anderson E; Aggrawal R
Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
[TBL] [Abstract][Full Text] [Related]
10. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in Myositis and Scleroderma.
Postolova A; Chen JK; Chung L
Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic inflammatory myopathies. A review].
Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.
Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ
Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597
[TBL] [Abstract][Full Text] [Related]
14. Pulse Dose Methylprednisolone Therapy for Adult Idiopathic Inflammatory Myopathy.
Raghu P; Manadan AM; Schmukler J; Mathur T; Block JA
Am J Ther; 2015; 22(4):244-7. PubMed ID: 25490616
[TBL] [Abstract][Full Text] [Related]
15. The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature.
Barsotti S; Cioffi E; Tripoli A; Tavoni A; D'Ascanio A; Mosca M; Neri R
Reumatismo; 2018 Jul; 70(2):78-84. PubMed ID: 29976041
[TBL] [Abstract][Full Text] [Related]
16. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid Monotherapy Is Usually Insufficient Treatment for Idiopathic Inflammatory Myopathy.
Mathur T; Manadan AM; Thiagarajan S; Hota B; Block JA
Am J Ther; 2015; 22(5):350-4. PubMed ID: 23797759
[TBL] [Abstract][Full Text] [Related]
19. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
20. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.
Bae SS; Lee YY; Shahbazian A; Wang J; Meriwether D; Golub I; Oganesian B; Dowd T; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2020 Nov; 59(11):3515-3525. PubMed ID: 32830270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]